SCHEMBL4848038

SCHEMBL4848038

COc1ccc(C(=O)C=Cc2cc(-c3ccccc3C)ccc2OCCN(C)C)c(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.47
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
TNFRSF1A P19438 1/20 0.42
SLC6A9 P48067 3/20 0.42
KDM4E B2RXH2 2/20 0.41
ROCK2 O75116 1/20 0.41
ROCK1 Q13464 1/20 0.41
APP P05067 2/20 0.40
MAPT P10636 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
LMNA P02545 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854790 0.92 ABCG2 (0.50) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL4848031 0.91 ABCG2 (0.46) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL4856317 0.91 ABCG2 (0.46) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL4848487 0.90 LMNA (0.46) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL4847516 0.89 ABCG2 (0.50) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL4849336 0.87 TNFRSF1A (0.44) PDE4APDE4BPDE4CPDE4DTNFRSF1A
SCHEMBL4848333 0.87 PDE4A (0.46) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL14280885 0.87 PDE4A (0.46) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL4853297 0.87 BCHE (0.52) ABCG2TNFRSF1AKDM4EMAPTL3MBTL1
SCHEMBL4846183 0.85 LMNA (0.45) ABCG2PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed